-transparent.png){kind=logo}
Alveolar epithelial cells produce many types of chemokines such as regulated on activation, normal T cells expressed and secreted (RANTES), eotaxin induced by interleukin (IL)-1 beta, or tumor necrosis factor (TNF)-alpha and may contribute to allergic disease by recruiting eosinophils. However, identification of the eosinophil chemotacic activity (ECA) release from A549 cells, an alveolar type II cell line, has not yet been completed. Recently, IL-16 was also reported to be a potent chemotactic stimulus for CD4(+) T lymphocytes and eosinophils in asthma and other pulmonary diseases. To test the possibility that alveolar epithelial cells produce IL-16, we analyzed RNA and culture supernatant from A549 cells by reverse transcription/ polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). The release of ECA from A549 cells was assessed using a blind-well chemotactic chamber. IL-16 release was increased in a concentration-dependent manner by stimulation with IL-1 beta or TNF-alpha. A549 cells also expressed IL-16 messenger RNA. The combination of IL-4 and IL-1 beta or TNF-alpha had an additive effect on IL-16 production. The release of ECA was induced by IL-1 beta or TNF-alpha in a dose-dependent manner. The combination of these cytokines had a greater effect than one alone. The blockade of eotaxin and IL-16 caused 70% inhibition of ECA, but anti-RANTES antibodies only caused 30% inhibition and anti-IL-8 antibodies failed to affect inhibition. These findings suggest a role for chemokines released by alveolar epithelial cells in the recruitment of eosinophils into the lung in pulmonary disorders such as asthma and interstitial lung diseases, and suggested that eotaxin and IL-16 are potent and effective eosinophil chemoattractants.
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
March 1997,
Internal medicine (Tokyo, Japan),
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
December 1992,
American journal of respiratory cell and molecular biology,
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
January 2014,
Methods in molecular biology (Clifton, N.J.),
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
January 1989,
Laboratory investigation; a journal of technical methods and pathology,
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
May 1997,
Biochemical Society transactions,
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
February 2000,
Immunology,
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
April 1997,
Blood,
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
January 1995,
The American journal of physiology,
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
August 2001,
Blood,
G Cheng, and
T Ueda, and
F Eda, and
M Arima, and
N Yoshida, and
T Fukuda
October 1998,
Inflammation research : official journal of the European Histamine Research Society ... [et al.],
